OTCMKTS:BFNH BioForce Nanosciences (BFNH) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free BFNH Stock Alerts $1.45 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$1.45▼$1.6350-Day Range$1.45▼$2.0052-Week Range$1.10▼$2.75Volume8,100 shsAverage Volume931 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get BioForce Nanosciences alerts: Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About BioForce Nanosciences Stock (OTCMKTS:BFNH)BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing. BioForce Nanosciences Holdings, Inc. was incorporated in 1999 and is based in Virginia Beach, Virginia.Read More BFNH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BFNH Stock News HeadlinesFebruary 6, 2024 | msn.comBuilding a DNA nanoparticle to be both carrier and medicineApril 22, 2023 | marketwatch.comBiomedical Applications Of Nanoscale Devices Market Report Include Detail about Competitor Analysis 2023-2030April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...August 20, 2022 | ca.finance.yahoo.comBioForce Nanosciences Holdings, Inc. (BFNH)January 23, 2022 | nasdaq.comBioForce Nanosciences Holdings Inc (BFNH)August 25, 2021 | barrons.comBioForce Nanosciences Holdings Inc.August 11, 2021 | finance.yahoo.comElement Global, Inc. (ELGL) Announces Signing MOU With Bioforce Nanosciences Holdings, Inc. (BFNH)See More Headlines Receive BFNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today4/24/2024Next Earnings (Estimated)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolOTCMKTS:BFNH CUSIPN/A CIK1310488 Webwww.bioforceeclipse.com Phone(757) 306-6090Fax757-306-6092Employees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-470,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-70,870.86% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-1.65 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Steven Gagnon (Age 62)Co-Chief Executive Officer Mr. John LaViolette (Age 63)Co-Chief Executive Officer Mr. Aleksandr Shapiro (Age 64)President Mr. Richard Kaiser (Age 58)CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director Key CompetitorsArrayitOTCMKTS:ARYCDiaSysOTCMKTS:DYXCOrthometrixOTCMKTS:OMRXPositiveIDOTCMKTS:PSID180 Life SciencesNASDAQ:ATNFWView All Competitors BFNH Stock Analysis - Frequently Asked Questions How have BFNH shares performed in 2024? BioForce Nanosciences' stock was trading at $2.01 at the start of the year. Since then, BFNH shares have decreased by 27.9% and is now trading at $1.45. View the best growth stocks for 2024 here. When is BioForce Nanosciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our BFNH earnings forecast. How were BioForce Nanosciences' earnings last quarter? BioForce Nanosciences Holdings, Inc. (OTCMKTS:BFNH) posted its quarterly earnings results on Monday, April, 1st. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of BioForce Nanosciences? Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BFNH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioForce Nanosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
